Quest Diagnostics Incorporated: connections
The people, owners, parents and subsidiaries, index lists, brands and deals tied to the company. Every line names its source.
In short
- 7 of the 20 people who filed Form 4 as insiders of Quest Diagnostics Incorporated since 2023 were insiders of another company too, for example at Visa Inc. (SEC Form 4 insider filings)
- The largest 13F holder, BlackRock, Inc., reported 8.4% of the shares for September 2026; the ten largest together 46.2%. (SEC Form 13F holdings)
- Quest Diagnostics Incorporated directly owns 3 registered entities in 2 countries. (GLEIF LEI register, level 2 (who owns whom))
- 37 acquisitions by Quest Diagnostics Incorporated on file; the largest with a price, LifeLabs (2024), for $986 million. (Deals on value.today (SEC filings, Wikidata))
Connections graph
Point at or tap a node to light up its ties; pick it to see each tie's source.
- ● leader
- ○ Form 4 insider
- ■ holder, deal or startup
- ◆ registered entity or brand
- ▲ index list
- dashed line: same group
Leaders
Leaders listed on the company's page, with their roles at other companies on the site.
- J. E. DavisCEOSource: Leaders on value.today
- Paul A. BrownFounderSource: Leaders on value.today
Insiders who are insiders elsewhere too
People who filed SEC Form 4 as directors, officers or 10% owners of this company and of another one in the same years.
- Denise M. MorrisonDirector · 2026-05-20Source: SEC Form 4 insider filings
- Vicky B. GreggDirector · 2026-10-21Also at:Acadia Healthcare Company, Inc.Source: SEC Form 4 insider filings
- Robert B. CarterDirector · 2026-10-21Also at:FedEx CorporationSource: SEC Form 4 insider filings
- Wright Lassiter IIIDirector · 2026-10-21Also at:Fortive CorporationSource: SEC Form 4 insider filings
- Timothy M. RingDirector · 2026-05-20Also at:Becton, Dickinson and CompanySource: SEC Form 4 insider filings
- Tracey DoiDirector · 2026-05-20Also at:Pentair plcSource: SEC Form 4 insider filings
- Timothy C. WentworthDirector · 2026-05-20Also at:Walgreens Boots Alliance, Inc.Source: SEC Form 4 insider filings
Largest institutional holders
From the newest quarter of SEC Form 13F filings, with their largest other holdings.
- BlackRock, Inc.8.41% of the shares · its #391 holding · 2026-09-30Source: SEC Form 13F holdings
- Vanguard Capital Management LLC6.57% of the shares · its #356 holding · 2026-09-30Source: SEC Form 13F holdings
- Vanguard Portfolio Management LLC5.56% of the shares · its #324 holding · 2026-09-30Source: SEC Form 13F holdings
- State Street Corp5.05% of the shares · its #349 holding · 2026-09-30Source: SEC Form 13F holdings
- Price T Rowe Associates Inc /MD/4.56% of the shares · its #149 holding · 2026-09-30Source: SEC Form 13F holdings
- Boston Partners4.22% of the shares · its #18 holding · 2026-09-30Source: SEC Form 13F holdings
- FMR LLC4.10% of the shares · its #275 holding · 2026-09-30Source: SEC Form 13F holdings
- Geode Capital Management, LLC2.88% of the shares · its #354 holding · 2026-09-30Source: SEC Form 13F holdings
- Jpmorgan Chase & Co2.62% of the shares · its #257 holding · 2026-09-30Source: SEC Form 13F holdings
- Morgan Stanley2.24% of the shares · its #329 holding · 2026-09-30Source: SEC Form 13F holdings
Parents, subsidiaries and group
Who owns whom, from the GLEIF register of legal entity identifiers.
- Blueprint Genetics OyDirect subsidiary
- QUEST DIAGNOSTICS HTAS INDIA PRIVATE LIMITEDDirect subsidiary
- QUEST DIAGNOSTICS INDIA PRIVATE LIMITEDDirect subsidiary
Index lists
Index lists on value.today that include the company.
- S&P 500MemberSource: Index lists on value.today
Deals and startup investments
Companies it bought or that bought it, and startups it invested in.
- LifeLabsBought 2024 for $986 millionSource: Buyer's annual report (SEC)
- AthenaBought 2011 for $740 millionSource: Buyer's annual report (SEC)
- CeleraBought 2011 for $670 millionSource: Buyer's annual report (SEC)
- Solstas Lab Parnters GroupBought 2014 for $572 millionSource: Buyer's annual report (SEC)
- Haystack Oncology, Inc.Bought 2023 for $392 millionSource: Buyer's annual report (SEC)
- Laboratory Business of Three Physician Groups in New YorkBought 2024 for $300 millionSource: Buyer's annual report (SEC)
- New York-PresbyterianBought 2023 for $275 millionSource: Buyer's annual report (SEC)
- UMassBought 2013 for $264 millionSource: Buyer's annual report (SEC)
- Allina HealthBought 2024 for $230 millionSource: Buyer's annual report (SEC)
- Mercy HealthBought 2021 for $225 millionSource: Buyer's annual report (SEC)